Atropine Weight and Risk of Postoperative Confusion in the Elderly
NCT ID: NCT03390751
Last Updated: 2020-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
130 participants
OBSERVATIONAL
2017-12-14
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Pharmacoepidemiological: identify factors associated with postoperative confusion
* Clinics: by favoring treatments with a low atropine load during anesthesia, the management of patients hospitalized in orthopedics. Similarly, stopping or re-evaluating treatments with a high atropine weight for scheduled surgery is an easy step to take.
* Socio-economic: by reducing the costs related to the occurrence of a confusional syndrome (over-treatment, prolonged hospital stay, loss of autonomy, institutionalization of patients...).
In total, the present study would improve the daily management of hospitalized patients and the practices of clinicians, by offering a decision-making aid.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hip Fracture Surgery in Elderly Patients
NCT01199276
Post-operative Delirium (POD) in Patients Undergoing Hip Fracture Surgery
NCT05105906
The DETEcT Study - Delirium in Elderly paTiEnts Admitted to Trauma
NCT02086981
Risk Early Warning Management for Postoperative Hip Fracture Rehabilitation and Delirium Prevention in Elderly Patients
NCT06966947
Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture
NCT04404959
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aged patients
Data collection of patients admitted to the orthopedic department of the University Hospital of Toulouse for surgical management of a fracture of the upper end of the femur in emergency or for the installation of a hip or knee prosthesis.
Data collection
The collection of data will be done by interrogation of the patient and his family / entourage and rereading of medical records
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
The collection of data will be done by interrogation of the patient and his family / entourage and rereading of medical records
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient able to understand and respond to the protocol
* No opposition to the collection of data of the patient or his / her designee
Exclusion Criteria
* Serious or moderate head trauma less than three months old
* Removing / installing prosthesis.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vincent Minville
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pierre-Paul-Riquet University Hospital
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Marie PIEL-JULIAN
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Vincent Minville, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01847-46
Identifier Type: REGISTRY
Identifier Source: secondary_id
RC31/17/0202
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.